Safety concerns raised over people with peripheral field loss

Article

Poor traffic gap judgement in patients with peripheral field loss (PFL) raises important safety concerns for their safety when crossing the road.

Poor traffic gap judgement in patients with peripheral field loss (PFL) raises important safety concerns for their safety when crossing the road, according to a study published online by Optometry & Vision Science.

Allen Cheong and colleagues from The Minnesota Laboratory for Low-Vision Research, University of Minnesota, USA recruited eight subjects with significant PFL and five age-matched control subjects. Each subject was asked to judge when they perceived it to be safe to cross a two-way, four-lane street while they stood on the curb. Eye movements were recorded by an eye tracker and movies of the eye-on-scene were made offline. Fixation patterns were classified into either relevant or irrelevant. Patients' street-crossing behaviour, habitual approach to street crossing and perceived difficulties were also assessed.

Compared with normal vision subjects, the PFL subjects identified 12% fewer crossable gaps while making 23% more errors by identifying a gap as crossable when it was, in fact, too short (p<0.05). These differences may be explained by the significantly smaller fixation area (p=0.006) and fewer fixations distributed to the relevant tasks (p=0.001). The patients' habitual approach to street crossing and perceived difficulties in street crossing were significantly correlated with traffic gap judgment performance.

The poor traffic gap judgment of patients with peripheral field loss raises concerns about their safety in crossing streets.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.